The High Costs of Chasing Immortality
John G. Carney, MEd |
John G. Carney, MEd, President and CEO of the Center, will present a free lecture on “The High Costs of Chasing Immortality” at the Center’s 2017 Bioethics Lecture Series on January 19, 2017, 4:30 to 5:30 pm CST, in person at the Kauffman Conference Center in Kansas City and on Facebook Live. To attend in person, please RSVP to cleyland@practicalbioethics.org.
Americans undoubtedly cherish the science of medicine, whether it be “moonshots” to cure fatal diseases, research to augment our genetic code, or the development of new “breakthrough” drugs for debilitating conditions.
Americans undoubtedly cherish the science of medicine, whether it be “moonshots” to cure fatal diseases, research to augment our genetic code, or the development of new “breakthrough” drugs for debilitating conditions.
But how good are we
at separating the financial considerations and “return on investment” from the
human factors involved in living with incurable diseases and chronic
conditions? What is the actual cost – in terms of patients’ lives? What is the
value of a day, a week, a month of additional life? Who gets to decide? Who
pays? Does every life get valued the same? Should it?
This brief but
thoughtful inquiry into the personal and societal questions that we face will
attempt to narrow the lens of focus to the human considerations involved in
prolonging life for those with life-limiting conditions.
- How should individual responsibilities
in managing care be measured?
- If we are going to shift from a world
that pays for services based on their availability to one that measures
“success” in terms of outcomes – whose outcomes are we adopting?
Patient-centered care
is designed to give patients a voice – not only in deciding how important it is
to pursue a critical path but in deciding what even the goals of care and
treatment ought to be. In doing so, we open ourselves up to a whole new set of
questions and a shift from the traditional paternalistic approach where “doctor
knows best.”
The whys and
wherefores of patient and proxy choices at the edge of life may just give us a
peek into how valuing patients decisions could change the dialogue about
outcomes and goals of care more generally.
-->
What we may find in
exploring our mortal natures is a different kind of answer - or certainly a
different set of questions that need to be answered rather than the elusive and
costly pursuit of immortality.
Labels: end of life planning, immortality, managing care, patient centered care
1 Comments:
This information is impressive; I am inspired with your post writing style & how continuously you describe this topic. After reading your post, thanks for taking the time to discuss this, I feel happy about it and I love learning more about this topic.
Is immortality possible| Elixir of immortality
Post a Comment
Subscribe to Post Comments [Atom]
<< Home